A perspective on stem cell modeling of amyotrophic lateral sclerosis
Authors:
- 2 December 2015
- journal article
- review article
- Published by Taylor & Francis in Cell Cycle
- Vol. 14 (23) , 3679-3688
Abstract
Amyotrophic lateral sclerosis is a complex neurodegenerative disease. Limitations in animal models have impeded progress in studying disease pathology and potential drug discovery. Here, we will review recent advances in the development of stem cell models for the study of ALS. Additionally, we will discuss the progress toward therapeutic development derived from these stem cell based assays.Keywords
This publication has 80 references indexed in Scilit:
- Autophagy induction enhances TDP43 turnover and survival in neuronal ALS modelsNature Chemical Biology, 2014
- Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor NeuronsCell Stem Cell, 2014
- Accelerated High-Yield Generation of Limb-Innervating Motor Neurons from Human Stem CellsJournal of Neuroscience, 2013
- Erosion of Dosage Compensation Impacts Human iPSC Disease ModelingCell Stem Cell, 2012
- Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementiaNature, 2011
- Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microgliaJournal of Neurochemistry, 2007
- Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS modelNature Neuroscience, 2007
- Directed Differentiation of Embryonic Stem Cells into Motor NeuronsCell, 2002
- Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.Proceedings of the National Academy of Sciences, 1996
- Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.Proceedings of the National Academy of Sciences, 1995